Importantly, while the increased surface levels of TIM-3 on NK cells in cancers induce NK-cell impairment [41], the in vitro and ex vivo TIM-3 blockade results in increased NK-cell cytotoxicity [39,40,104]. Here, HAVCR2 is linked to cancer.